Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)
SEOUL, South Korea--(BUSINESS WIRE)--Oct 23, 2023--
Source: eagletribune.com
Jongsoo Lee News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jongsoo Lee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jongsoo Lee Today - Breaking & Trending Today
Genexine's long-acting growth hormone meets Phase 3 primary endpoint
SEOUL, South Korea, August 31, 2023--Genexine (KOSDAQ:095700, CEO Neil Warma), a publicly traded, clinical-staged Korean biopharmaceutical company committed to the discovery and development of novel biologics for the treatment of unmet medical needs, today announced positive topline results from the multi-center, randomized, open-label, active-controlled pivotal phase 3 study (CTJ101PGHD301) being conducted in China to evaluate the efficacy and safety of eftansomatropin alfa (Genexine’s propriet
Source: yahoo.com
Genexine Abstract on GX-188E and GX-I7 Triple Combination Therapy in HNSCC Is Released at 2023 ASCO Annual Meeting
SEOUL, South Korea--(BUSINESS WIRE)--May 26, 2023--
Source: wsiltv.com
Joining the club? Possible South Korean entry to G-7 raises questions
The G-7 -- the U.S., Canada, France, Britain, Germany, Italy and Japan -- is widely considered one of the world's more exclusive political clubs, and the possibility of South Korea getting a seat at the table is prompting urgent but hushed debate in Seoul coffee shops - and beyond.
Source: washingtontimes.com
Genexine's First-in-Class Therapeutic DNA Vaccine Shows Significant Potential to Extend Survival in Late-Stage Cervical Cancer
Late-Breaking presentation of phase 2 results from a clinical trial of GX-188E in combination with KEYTRUDA(pembrolizumab) demonstrates anti-tumor benefit in heavily pre-treated, recurrent and advanced
Source: finanznachrichten.de